Home Cart Sign in  
Chemical Structure| 724424-43-5 Chemical Structure| 724424-43-5

Structure of CE-224535
CAS No.: 724424-43-5

Chemical Structure| 724424-43-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CE-224535 is a selective P2X7 receptor antagonist.

Synonyms: PF-04905428

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CE-224535

CAS No. :724424-43-5
Formula : C22H29ClN4O6
M.W : 480.94
SMILES Code : O=C(NCC1(O)CCCCCC1)C2=CC(N(C(N3C[C@@H](O)COC)=O)N=CC3=O)=CC=C2Cl
Synonyms :
PF-04905428
MDL No. :MFCD27665471

Safety of CE-224535

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00446784 Arthritis, Rheumatoid Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site Miami, Florida, United States, 33169 Pfizer Investigational Site Ocala, Florida, United States, 34471 Pfizer Investigational Site Ocala, Florida, United States, 34474 United States, Michigan Pfizer Investigational Site Kalamazoo, Michigan, United States, 49007 United States, Pennsylvania Pfizer Investigational Site Ducansville, Pennsylvania, United States, 16635 Less <<
NCT00782600 Rheumatoid Arthritis Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT00628095 Arthritis, Rheumatoid Phase 2 Phase 3 Completed - -
NCT00838058 Rheumatoid Arthritis ... More >> Healthy Volunteers Less << Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT00418782 Osteoarthritis Phase 2 Terminated(Results of interim ... More >>analysis indicate lack of efficacy when compared to placebo.) Less << - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.08mL

0.42mL

0.21mL

10.40mL

2.08mL

1.04mL

20.79mL

4.16mL

2.08mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories